Clinical Trial Update: Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a multi-agent regimen of cyclophosphamide, doxorubicin, vincristine with irinotecan and temozolomide in Ewing sarcoma and bone cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Ewing Sarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: Stanford University | Conditions: Bone Cancer, Ewing's Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2017-02-02